Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline A Austin

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Molecular Pharmacology|January 9, 2007
Differential selection of acridine resistance mutations in human DNA topoisomerase IIbeta is dependent on the acridine structureChrysoula Leontiou, Gary P Watters, Kathryn L Gilroy, et al.
International Journal of Molecular Sciences|September 19, 2018
TOP2B: The First Thirty YearsCaroline A Austin, Ka C Lee, Rebecca L Swan, et al.
Molecular Neurobiology|July 13, 2022
TOP2B Is Required to Maintain the Adrenergic Neural Phenotype and for ATRA-Induced Differentiation of SH-SY5Y Neuroblastoma CellsMushtaq M Khazeem, John W Casement, George Schlossmacher, et al.
Biology Open|October 14, 2015
Genome-wide ChIP-seq analysis of human TOP2B occupancy in MCF7 breast cancer epithelial cellsCatriona M Manville, Kayleigh Smith, Zbyslaw Sondka, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2012
Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximityIan G Cowell, Zbyslaw Sondka, Kayleigh Smith, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2022
Disease-associated mutations in topoisomerase IIβ result in defective NK cellsLori Broderick, Gwendolyn M Clay, Robert H Blum, et al.
Biology Open|December 6, 2012
MRE11 facilitates the removal of human topoisomerase II complexes from genomic DNAKa Cheong Lee, Kay Padget, Hannah Curtis, et al.
Journal of Medicinal Chemistry|March 22, 2021
Structure-Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase IIβ InteractionsAnna Jirkovská, Galina Karabanovich, Jan Kubeš, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 30, 2024
Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damageVeronika Keresteš, Jan Kubeš, Lenka Applová, et al.
Nucleic Acids Research|October 10, 2022
Two type I topoisomerases maintain DNA topology in human mitochondriaKatja E Menger, James Chapman, Héctor Díaz-Maldonado, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Molecular Pharmacology|January 9, 2007
Differential selection of acridine resistance mutations in human DNA topoisomerase IIbeta is dependent on the acridine structureChrysoula Leontiou, Gary P Watters, Kathryn L Gilroy, et al.
International Journal of Molecular Sciences|September 19, 2018
TOP2B: The First Thirty YearsCaroline A Austin, Ka C Lee, Rebecca L Swan, et al.
Molecular Neurobiology|July 13, 2022
TOP2B Is Required to Maintain the Adrenergic Neural Phenotype and for ATRA-Induced Differentiation of SH-SY5Y Neuroblastoma CellsMushtaq M Khazeem, John W Casement, George Schlossmacher, et al.
Biology Open|October 14, 2015
Genome-wide ChIP-seq analysis of human TOP2B occupancy in MCF7 breast cancer epithelial cellsCatriona M Manville, Kayleigh Smith, Zbyslaw Sondka, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2012
Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximityIan G Cowell, Zbyslaw Sondka, Kayleigh Smith, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2022
Disease-associated mutations in topoisomerase IIβ result in defective NK cellsLori Broderick, Gwendolyn M Clay, Robert H Blum, et al.
Biology Open|December 6, 2012
MRE11 facilitates the removal of human topoisomerase II complexes from genomic DNAKa Cheong Lee, Kay Padget, Hannah Curtis, et al.
Journal of Medicinal Chemistry|March 22, 2021
Structure-Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase IIβ InteractionsAnna Jirkovská, Galina Karabanovich, Jan Kubeš, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 30, 2024
Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damageVeronika Keresteš, Jan Kubeš, Lenka Applová, et al.
Nucleic Acids Research|October 10, 2022
Two type I topoisomerases maintain DNA topology in human mitochondriaKatja E Menger, James Chapman, Héctor Díaz-Maldonado, et al.
Pageof 8